Imbria Pharmaceuticals
Drug DiscoveryWebsite
Operator of a clinical-stage company designed to develop novel therapies for patients with life-altering cardiometabolic disorders. The company focused on restoring or improving the cell's ability to ...
Valuation
$131.7M
Market implied
Share Price
N/A
Total Raised
$151.9M
Last Round
Later Stage VC (Series B)
Dec 2025
Latest Funding Round
Later Stage VC (Series B)
Dec 16, 2025
$66.7M
raised
Investors
+9 other investors